Position in BLLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,117,200
+$2,812,334 QoQ
Shares Held
25,981
+572.7% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 156 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $2,165,536,060 across 26 Diagnostics & Research names. BLLN ranks #20 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
|
948,639 | $355,777,570 | |
| 2 | NTRA |
Natera, Inc.
|
1,279,255 | $347,253,769 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
641,637 | $321,691,125 | |
| 4 | ICLR |
Icon PLC
|
1,357,143 | $235,749,309 | |
| 5 | A |
Agilent Technologies, Inc.
|
1,486,187 | $197,410,218 | |
| 6 | GH |
Guardant Health, Inc.
|
1,255,658 | $188,386,369 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
234,537 | $124,208,448 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
466,234 | $90,085,733 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,117,200 | 25,981 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $304,866 | 3,862 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||